Investment Opportunity: Knox — Help Kids with Asthma!

Join CrowdSmart to participate in the KNOX startup evaluation. As a member of the evaluation team, you get to participate in the whole due diligence process.

If the evaluation team together with our AI comes to the conclusion that we invest in KNOX, all members of the evaluation team can invest too, free of carried interest or other fees, starting as low as $1000.

KNOX has developed Aluna, a Respiratory management system consisting of a portable spirometer and gamified app to detect early signs of exacerbations.

It detects Asthma incidences days before they flare up, allowing early intervention and helping prevent ER visits.

KNOX, in collaboration with UCSF, won the prestigious $225K National Science Foundation award to conduct a 300 subject study which was completed in June 2017. The $500K Phase II of the same study will begin in November 2017.

If you have expertise in managing Asthma for yourself or a loved one, even if you don’t plan to invest, please join the evaluation team, your insights will be very appreciated.

More about this opportunity on KNOX’s CrowdSmart overview page.